Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IL-10 anticorps (Biotin)

IL10 Reactivité: Humain, Virus WB, ELISA Hôte: Rat Monoclonal JES3 Biotin
N° du produit ABIN2689726
  • Antigène Voir toutes IL-10 (IL10) Anticorps
    IL-10 (IL10) (Interleukin 10 (IL10))
    Reactivité
    • 153
    • 95
    • 51
    • 19
    • 17
    • 11
    • 8
    • 7
    • 6
    • 6
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain, Virus
    Hôte
    • 125
    • 78
    • 64
    • 4
    • 3
    • 1
    Rat
    Clonalité
    • 141
    • 128
    • 1
    Monoclonal
    Conjugué
    • 170
    • 34
    • 12
    • 11
    • 8
    • 6
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Cet anticorp IL-10 est conjugé à/à la Biotin
    Application
    • 169
    • 125
    • 81
    • 70
    • 43
    • 29
    • 28
    • 19
    • 17
    • 15
    • 15
    • 14
    • 14
    • 13
    • 12
    • 8
    • 7
    • 7
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Marque
    BD Pharmingen™
    Attributs du produit
    The JES3-12G8 antibody reacts with human interleukin-10 (IL-10) and viral IL-10. The immunogen used to generate the JES3-12G8 hybridoma was human IL-10. This is a neutralizing antibody. This antibody is routinely tested by ELISA detection. Other applications were tested during antibody development only or reported in the literature.

    BD Pharmingen™ Biotin Anti-Human and Viral IL-10 - Biotin - Clone JES3-12G8 - Isotype Rat IgG2a - Reactivity Hu, Vir - 0.5 mg
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogène
    Human IL-10
    Clone
    JES3
    Isotype
    IgG2a
    Top Product
    Discover our top product IL10 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Aqueous buffered solution containing protein stabilizer and ≤0.09 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    The antibody was conjugated with biotin under optimum conditions, and unreacted biotin was removed.
    Stock
    4 °C
    Stockage commentaire
    Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
  • Burdin, Péronne, Banchereau, Rousset: "Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10." dans: The Journal of experimental medicine, Vol. 177, Issue 2, pp. 295-304, (1993) (PubMed).

    Abrams, Roncarolo, Yssel, Andersson, Gleich, Silver: "Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples." dans: Immunological reviews, Vol. 127, Issue 9-10, pp. 5-24, (1992) (PubMed).

    Gotlieb, Abrams, Watson, Velu, Berek, Martínez-Maza: "Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers." dans: Cytokine, Vol. 4, Issue 5, pp. 385-90, (1992) (PubMed).

    Yssel, De Waal Malefyt, Roncarolo, Abrams, Lahesmaa, Spits, de Vries: "IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 149, Issue 7, pp. 2378-84, (1992) (PubMed).

  • Antigène
    IL-10 (IL10) (Interleukin 10 (IL10))
    Autre désignation
    IL-10 (IL10 Produits)
    Synonymes
    anticorps CSIF, anticorps GVHDS, anticorps IL-10, anticorps IL10A, anticorps TGIF, anticorps Il-10, anticorps IL10X, anticorps interleukin 10, anticorps IL10, anticorps Il10
    Pathways
    Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints
Vous êtes ici:
Support technique